Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

SEREMI de Salud Grants Registration to Chile's First Finished Product Featuring Setria® Glutathione

ingredients within Kirin Holdings' Health Science group. Building on over 75 years of fermentation innovation and Kirin's 100+ year legacy of fermentation excellence, Kyowa delivers premium, science-backed branded ingredients to the nutraceutical,...

Roquette Highlights Scalable Innovations in Drug Delivery

promising formulations into scalable commercial realities. “As the pharmaceutical industry accelerates innovation, from GLP-1 therapies to complex biologics, the pressure to deliver manufacturing reliability, consistent supply, and robust...

X-Therma Launched XT-NoVo® and TimeSeal® Platform to Advance On-Demand Regenerative Medicine Beyond Cold Chain Constraints

Drug Administration (FDA) granted Breakthrough Device status to XT-ViVo® and TimeSeal® for human kidney preservation up to 120 hours for transplant. For more information please visit, www.x-therma.com

IMAAVY® (nipocalimab-aahu) demonstrated rapid onset and durable hemoglobin response in a pivotal Phase 2/3 study of warm autoimmune hemolytic anemia (wAIHA), a disease with no FDA-approved therapies

versus placebo by 24 weeks. Overall, patients treated with this dose of IMAAVY showed a mean Hgb improvement of at least 1g/dL as early as Week 1.1,c To be presented at the European Hematology Association (EHA) 2026 Congress, these results mark an...

Exilby®, a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain, Receives Its First European Marketing Authorization from VERTANICAL; Pivotal U.S. Phase 3 Trial Underway

VERTANICAL announced that Exilby® (VER-01) has received marketing authorization in Germany for the treatment of chronic low back pain with a radicular (neuropathic) component. The authorization marks a major milestone for VERTANICAL and highlights...

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

to moderate Alzheimer’s disease who were receiving ZUNVEYL. The BEACON study evaluated provider-reported outcomes from 21 investigators treating 162 long-term care patients with mild to moderate Alzheimer’s disease who received ZUNVEYL for 3 to 12...

TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

global market value of more than $5 billion and are dispensed across primary care, pediatric, and hospital settings in over 100 countries. Because these products are already in the field across more than 100 countries, their packaging is actively...

Growing Demand for Digital Pharmacy Underscores TelyRx Surpassing 1 Million Prescriptions

TelyRx Holdings Inc. a technology-enabled healthcare and online pharmacy platform focused on expanding access to FDA-approved medications across the United States, today announced it has surpassed one million prescriptions filled nationwide since...

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

have been dermatologist supervised tested for safety and sensitivity. Clinical testing of the 3 step facial regimen showed 100% of participants reported their skin looked and felt smoother and 97% felt their skin looked younger. Additionally, the...

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

Brain Navi Biotechnology announced that its KrystoLens, the single-use neuro-endoscope, has officially received certification from the Taiwan Food and Drug Administration (TFDA), marking an important milestone in the company's development in...

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

SK bioscience announced that it has been designated as a supplier of influenza vaccines for UNICEF's 2026 immunization programs and has begun shipments for countries in the Southern Hemisphere. Beginning in September, the company will also...

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

Niagen in clinical studies exploring IV and injectable administration. Currently, the program supports more than 175 ongoing and developing research studies. In addition, the Company recently initiated the Niagen Bioscience Trainee Grant Program,...

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

Medella Springs, a wellness brand focused on nature-inspired supplements and whole-body support, is helping families navigate the growing conversation around focus, attention, and daily cognitive wellness with AddiVance, a drug-free, non-stimulant...

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

pathogens in a single test. A core feature of Seegene's syndromic real-time PCR technology is its ability to detect up to 14 pathogens that cause similar signs and symptoms in a single tube while providing quantitative information to support more...

Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

more confidently in their daily routine, while building on the trusted performance associated with the CONTOUR® brand.” 1 CONTOUR COMFORT pen needles have been developed to support ease of use in daily therapy. They combine advanced 5-bevel tip...

XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

Administration (FDA) has approved XOCOVA® (ensitrelvir), an oral antiviral, for post-exposure prophylaxis (PEP) of COVID‑19 in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19.3 This approval...

EU Approves Expanded Label for Opdivo® + AVD in Advanced Hodgkin Lymphoma

in combination with doxorubicin, vinblastine and dacarbazine (AVD) for the treatment of adult and adolescent patients 12 years of age and older with previously untreated Stage III or IV classical Hodgkin Lymphoma (cHL). This approval marks a...

FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy

mutated and non-BRCA HRR gene-mutated mCRPC. Prostate cancer is the second most common cancer in men, with approximately 1 in 8 diagnosed during their lifetime.2 mCRPC occurs when prostate cancer grows and spreads to other parts of the body despite...

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

program has generated valuable insights into ALS disease biology, including pharmacogenomic response associated with the UNC13A genotype, biomarker data collected at seven longitudinal time points, and a comprehensive analysis of the "Floor Effect"...

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

product (LBP) indicated in the United States to prevent recurrent Clostridioides difficile infection (rCDI) in individuals 18 years of age and older following antibacterial treatment for rCDI. Under the agreement, the parties will work jointly to...